Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

HSR23-105: Real-World Dosing Patterns in Patients With Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Treated With Brigatinib in the Front-Line (FL) Setting in the United States: A Claims Database Analysis

Edmund W. Tai,Huamao Mark Lin,Yanyu Wu, Yin Wan,Magdaliz Gorritz, Xiaoyu Zhou,Chi-Chang Chen,Yuanbin Chen

Journal of The National Comprehensive Cancer Network（2023）

Cited 0|Views2
No score
Abstract
"HSR23-105: Real-World Dosing Patterns in Patients With Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Treated With Brigatinib in the Front-Line (FL) Setting in the United States: A Claims Database Analysis" published on 31 Mar 2023 by National Comprehensive Cancer Network.
More
Translated text
Key words
anaplastic lymphoma kinase positive,lung cancer,cell lung cancer,non–small cell lung cancer,real-world,front-line
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined